MedPath

Strength Training in Fibromyalgia on Balance, Neuromuscular Performance and Symptoms

Not Applicable
Recruiting
Conditions
Fibromyalgia
Registration Number
NCT05646641
Lead Sponsor
University of Beira Interior
Brief Summary

The purpose of this study is verify the effects of a 8 weeks strength training, on balance, neuromuscular performance and symptomatology of fibromyalgia.

Detailed Description

Thirty participants will be recruited. Volunteers will be randomly assigned to the control group or experimental group. Before the training period, symptoms, balance and neuromuscular performance will be assessed. Participants in the experimental group will perform strength training twice a week (50 min each) for eight weeks. Then, four weeks of detraining will be completed.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • medical diagnosis of fibromyalgia according to the American College of Rheumatology criteria
  • at least 18 years old
Exclusion Criteria
  • severe comorbidity or any other type of condition that negatively influences participation in the training program
  • cognitive disorders
  • heart problems
  • surgeries or fractures in the last 6 months
  • regular practice of physical exercises in the least 3 months before program.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Neuromuscular performanceChange from week 9 neuromuscular performance at week 12

Optical measurement system consisting of two transmitting and receiving cells to assess vertical jump and medicine ball to assess strength of the upper limbs.

BalanceChange from week 9 balance at week 12

Force plate

Secondary Outcome Measures
NameTimeMethod
Quality of sleepbaseline and everyday until the week 12

Visual Analogue Scale (VAS). The scoring range will be from 0 to 100, in which the higher the value, the greater the intensity. During non-presencial days, participants will respond daily the intensity with a cell phone application developed for this purpose.

Fatiguebaseline and everyday until the week 12

Visual Analogue Scale (VAS). The scoring range will be from 0 to 100, in which the higher the value, the greater the intensity. During non-presencial days, participants will respond daily the intensity with a cell phone application developed for this purpose.

Fibromyalgia impact questionnaireBaseline, week 9, week 12

Questionnaire to ccess information on the functional capacity and health status of individuals with fibromyalgia. Composed of 20 questions. , the values vary from 0 to 100, in which the higher the value, the greater the impact of fibromyalgia.

Pain intensitybaseline and everyday until the week 12

Visual Analogue Scale (VAS). The scoring range will be from 0 to 100, in which the higher the value, the greater the intensity. During non-presencial days, participants will respond daily the intensity with a cell phone application developed for this purpose.

Mood statebaseline and everyday until the week 12

Visual Analogue Scale (VAS). The scoring range will be from 0 to 100, in which the higher the value, the greater the intensity. During non-presencial days, participants will respond daily the intensity with a cell phone application developed for this purpose.

Anxietybaseline and everyday until the week 12

Visual Analogue Scale (VAS). The scoring range will be from 0 to 100, in which the higher the value, the greater the intensity. During non-presencial days, participants will respond daily the intensity with a cell phone application developed for this purpose.

Trial Locations

Locations (1)

Federal University of Pernambuco

🇧🇷

Recife, Pernambuco, Brazil

Federal University of Pernambuco
🇧🇷Recife, Pernambuco, Brazil
Gisela Siqueira, PhD
Contact
55 81 8107-5155
gisela.siqueira@ufpe.br
Angélica Tenório, PhD
Contact
21268491
angelica.stenorio@ufpe.br

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.